Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance
2021 · Nature Communications · 134 citations
https://doi.org/10.1038/s41467-021-24108-6
L
Lanjuan Mi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
278
Citations
6
h-index
5
i10-index
Lanjuan Mi is an academic researcher from Huzhou University. The author has contributed to research in topics: Epigenetics and DNA Methylation & Pluripotent Stem Cells Research & Mitochondrial Function and Pathology. The author has an h-index of 6, co-authored 37 publications.
ORCID: 0009-0005-3110-1423Papers by this author
worksElevated nonhomologous end-joining by AATF enables efficient DNA damage repair and therapeutic resistance in glioblastoma
2025 · Nature Communications · 6 citations
https://doi.org/10.1038/s41467-025-60228-z
Supplementary Table S7 from Phosphocreatine Promotes Epigenetic Reprogramming to Facilitate Glioblastoma Growth Through Stabilizing BRD2
2024 · 0 citations
https://doi.org/10.1158/2159-8290.26467084
Supplementary Table S4 from Phosphocreatine Promotes Epigenetic Reprogramming to Facilitate Glioblastoma Growth Through Stabilizing BRD2
2024 · 0 citations
https://doi.org/10.1158/2159-8290.26467099
Supplementary Table S5 from Phosphocreatine Promotes Epigenetic Reprogramming to Facilitate Glioblastoma Growth Through Stabilizing BRD2
2024 · 0 citations
https://doi.org/10.1158/2159-8290.26467093.v1
Supplementary Table S7 from Phosphocreatine Promotes Epigenetic Reprogramming to Facilitate Glioblastoma Growth Through Stabilizing BRD2
2024 · 0 citations
https://doi.org/10.1158/2159-8290.26467084.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat